Amyloids are fibrillar nanostructures of proteins that are assembled in several physiological processes in human cells (e.g., hormone storage) but also during the course of infectious (prion) and noninfectious (nonprion) diseases such as Creutzfeldt-Jakob and Alzheimer's diseases, respectively. How the amyloid state, a state accessible to all proteins and peptides, can be exploited for functional purposes but also have detrimental effects remains to be determined. Here, we measure the nanomechanical properties of different amyloids and link them to features found in their structure models. Specifically, we use shape fluctuation analysis and sonication-induced scission in combination with full-atom molecular dynamics simulations to reveal that the amyloid fibrils of the mammalian prion protein PrP are mechanically unstable, most likely due to a very low hydrogen bond density in the fibril structure. Interestingly, amyloid fibrils formed by HET-s, a fungal protein that can confer functional prion behavior, have a much higher Young's modulus and tensile strength than those of PrP, i.e., they are much stiffer and stronger due to a tighter packing in the fibril structure. By contrast, amyloids of the proteins RIP1/RIP3 that have been shown to be of functional use in human cells are significantly stiffer than PrP fibrils but have comparable tensile strength. Our study demonstrates that amyloids are biomaterials with a broad range of nanomechanical properties, and we provide further support for the strong link between nanomechanics and b-sheet characteristics in the amyloid core. FIGURE 3 Material properties of amyloid fibrils determined by SMD simulations. All quantities are expressed as the mean 5 SD. (A) VMD-generated schematics of fibril models of mouse PrP, nonprion proteins, and HET-s prion. (B) Material property chart derived from SMD simulations for all fibril models (number of independent pulling experiments, N R 3). (C) Modulus of resilience of fibrils calculated from stress-strain curves. IS2 and BH2 fibrils are significantly less resilient than other fibril models (*p < 0.04 by unpaired t-test). (D) Correlation between HBD and mechanical properties measured experimentally (see Fig. 2 ). Black lines are linear fits to the data and R 2 is the correlation coefficient.
INTRODUCTION
Amyloid fibril self-assembly is a generic property of polypeptide chains, at least under appropriate solution conditions. By definition, amyloids are composed of one or more unbranched protofilaments in which b-sheets run along the fibril axis with the individual b-strands arranged perpendicular to it. b-strands in the fibril core are held together by a densely packed network of hydrogen bonds, which confers extraordinary mechanical properties to the amyloid fold, rendering it as stiff as silk and as strong as steel (1) (2) (3) (4) (5) . In addition, the amyloid state of a protein can be thermodynamically more stable than its native state (6) . Hence, these properties make amyloids very promising building blocks for next-generation nanomaterials. For instance, they can be used to make conducting nanowires (7) or drug delivery vehicles (8) .
Despite the commonalities of the overall architecture of amyloids, their structural details can vary significantly (9) , suggesting a high level of polymorphism that is most likely associated with their different functional and detrimental effects. Amyloids are exploited in several physiological processes in human cells, for instance, as a scaffold for the synthesis of melanin (10) and as a storage apparatus for protein hormones of the endocrine system (11) . However, amyloid fibrils are more often mentioned in the context of human disease, particularly neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases (12) , where they can be found as intra-or extracellular deposits. In some cases, the amyloid or amyloid-like form of the protein associated with a disease is even infectious, as is the case with the prion protein PrP, which can cause transmissible Creutzfeldt-Jakob disease in humans and mad cow disease in cattle. The ability of bona fide prions to propagate from cell to cell or organism to organism is suggested to be associated with the high seeding potential of their amyloid fibrils, which is in part due to a high rate of fragmentation (13, 14) . Many prions have a very low rate of spontaneous de novo generation of fibrils (15) , so fragmentation is likely responsible for providing new conversion and growth sites for prion propagation. Hence, kinetics of amyloid formation (13) and the nanomechanics of fibril structure (16) seem to be key to amyloid-based infectivity. However, whether amyloid fibrils formed by the mammalian prion protein and other prions have clearly distinct nanomechanical properties, whether they differ from those of functional amyloids, and if so, based on which molecular features, remains unclear.
Atomic force microscopy (AFM) and transmission electron microscopy (TEM) have been very useful techniques for studying the nanoscale properties of proteins and amyloids. AFM in particular has been used to investigate the nucleation process of amyloid formation (17, 18) , fibril assembly, and the topological characteristics and diversity of fibrils (19) (20) (21) (22) . Of interest here is the use of AFM to determine the mechanical properties of amyloid fibrils such as persistence length (1, 2, 4, 23) , Young's (elastic) modulus (1, 5, 24) , and strength (25) . Constant-velocity steered molecular dynamics (SMD) simulations have also been used effectively to calculate the rupture force in tensile deformation simulations, allowing for estimation of the ultimate strength and Young's (elastic) modulus of amyloid fibrils (26) (27) (28) .
Here, we combine AFM and TEM imaging with SMD to provide quantitative nanomechanical measurements of different amyloids, including amyloids that have been associated with functional or disease-causing behavior and with prion or nonprion behavior. We reveal that these amyloids can have very different nanomechanical properties that are consistent with the differences in intermolecular interactions in their respective structural models.
MATERIALS AND METHODS
Additional details on the methods and any associated references are available in the Supporting Material of this article.
Preparation of amyloids
Proteins were expressed and purified as described in previous studies (24, 29) and in the Supporting Material. Nanofibrils of mouse PrP, human lysozyme, and bovine insulin were obtained after resuspending lyophilized protein powders in appropriate solvents with or without shaking. Different polymorphs were obtained for PrP: ''W'' and ''FV'' are wild-type and FV mutant, respectively, of mouse PrP(23-231) (see Supporting Materials and Methods for details). Human functional fibrils were obtained from the void fractions of the final gel filtration chromatography steps as described previously (29) . To refold and generate fibrils from sup35N and sup35NM yeast prions, the His 6 -tagged proteins were diluted in buffers without denaturants. For HET-s(218-289), the renaturing reaction was done as previously described (30) .
Experimental determination of the nanomechanical properties
The Young's (elastic) modulus of the fibrils was measured by deriving the topographical data obtained by AFM and TEM (Figs. S1 and S2), as described previously (1, 23, 24) . The yield (tensile) strength, s*, of the fibrils was measured by using a sonication-induced fragmentation technique described earlier (25, 31) and adapted to amyloids in this study to account for fine variations of cross-sectional area. In particular, the fibril diameter, d, that represented a circular cross section in the model developed by Huang et al. (25) was replaced here by the term (h Â w) 1/2 , which represents a rectangular cross section (see next section for details), where h is the AFM height and w the fibril width measured by TEM:
In brief, this model predicts that there is a fibril threshold length, called L lim , below which the shear forces exerted on the fibrils that are trapped in fluid velocity fields, caused by collapsing cavitation bubbles, are not high enough to break them further. Hence, after prolonged sonication time, fibril length distribution reaches a plateau and the size of fragments that belong to a sample fall in a ''terminal range'' defined by [L lim /2, L lim ]. However, for a given sample, both the cross-sectional area and the intrinsic strength can vary, which leads to an even broader distribution of fibril fragment lengths, L. This can be taken into account by performing linear regression through the extremities of the distribution. We chose to represent the extremities by the 5-15 data points corresponding to the smallest and longest aspect ratios, L/(h Â w) 1/2 ( Fig. 1 
The tensile strength is therefore obtained by combining the results of Eq. 2 with Eq. 1. Using the absolute error 5 (2sÀS)/2 provides a simple way of including all possible sources of error that could affect the measurements as well as accounting for the strength variability within a given sample.
Using this method provides two great advantages. First, it is possible to check the accuracy of the model described by Eq. 1 by verifying that a linear relationship exists between the limiting length and the size of the cross section. Hence, it provides strong support for the assumptions made about the size of the cavitation bubble (~10 mm) and about fluid viscosity (~0.01 Pa) and speed (~1 km s À1 ) during the collapse of the cavitation bubble. Second, it removes a discussion on the fraction of points to include when establishing the edges of the distribution. The fragment length will always be distributed in the terminal ranges, and prolonged sonication can reliably reveal at least the position of the lower edge of the terminal distribution, which corresponds to the lowest possible strength of any fibril sample. For further details on the experimental determination of the nanomechanical properties, refer to the Supporting Material.
Model for fibril cross sections
For calculations of both Young's modulus and mechanical strength, a rectangular cross section was chosen, because the morphology of the fibrils (see TEM images in Fig. S2 ) resembles that of flat ribbons (4). In flat ribbons, the protofilaments stack next to each other in a lateral fashion, giving rise to the ''flat tape'' structure of the mature fibril. Some fibrils may not exactly have a ''flat tape'' structure (see Fig. S2 ). However, AFM heights and TEM widths differ significantly in all samples in this study (Figs. S3, S4 and S5), even for insulin fibrils, for which previous studies suggested a helical arrangement of protofilaments (32) . When this prevalent difference in measured heights and widths among fibrils is taken into consideration, a rectangular-cross-section model yields reliable and consistent values of I across different samples.
Sonication experimental details
The sonicator (Qsonica Q500) was operated with a 2-mm-diameter microtip whose vibrational frequency and amplitude were 20 kHz and 25%, respectively. Sonicating power was at least 30 W cm À2 , ensuring cavitation. A 5 s on/3 s off pulse cycle was applied, and a cooling system insured that the fibril solutions remained at a temperature below 15 C for the entire duration of the experiment. Immediately before sonication, functional fibrils RIP1, RIP1/RIP3 complex, and TRIF concentrations were adjusted to 10-20 mg/mL in 20 mM Tris (pH 7.4) and 150 mM NaCl buffer. All other samples were diluted in deionized water to the same concentration. Fibril fragment sizes were measured using the ImageJ free software tool to analyze TEM images and Asylum Research (Santa Barbara, CA) macros and custom scripts were written in IgorPro (WaveMetrics, Lake Oswego, OR) to analyze AFM images.
Molecular dynamics simulations
Fibrillar structures were prepared in VMD (see the Supporting Material for details on the models). All simulations were carried out in NAMD (33), version 2.10, using the CHARMM22 all-hydrogen force field with CMAP correction (34) and a cutoff distance of 12 Å for nonbonded interactions. Particle-mesh Ewald was used for calculating long-range electrostatics. The simulations were carried out on a 2.00 GHz Genuine Intel Xeon central processing unit using CUDA extension running on an NVIDIA GeForce GTX 780 graphics card. Each protein fibril model was solvated in a periodic box of TIP3P water molecules with at least 15 Å buffer distance between protein atoms and the side of the box, and Na þ /Clions were added to neutralize the system. Each system was minimized and heated to 300 K in 30 ps. The systems were equilibrated under NVT conditions for 100 ps with protein backbone atoms restrained and then under As examples, the TRs and average limiting lengths, L lim , are shown at 5 nm (pink) and at 11 nm (blue) for insulin and PrP fibrils, respectively (see Figs. S8 and S9 for details). TR lower limits correspond to small fragments, represented by the most prominent peaks of the length distributions (B and D) for PrP and insulin, respectively. TR upper limits correspond to <L lim >. s* is the tensile strength (values are represented as the mean 5 SD).
NPT conditions for 120 ps with gradual release of the positional restraints. Langevin dynamics were used to keep the temperature at 300 K and a modified Nos e-Hoover barostat was used to maintain the pressure at 1 bar. The SHAKE algorithm was used to fix the length of covalent bonds involving hydrogen atoms, allowing for a 2 fs integration time step. The production run was performed under NPT conditions at 300 K and 1 bar for 20 ns and without positional restraints. The last 10 ns of the production runs were used to calculate the interlayer interactions. The van der Waals (vdW) energies and the number of hydrogen bonds between the layers were computed using VMD scripting, with a donor-hydrogen-acceptor angle cutoff of 30 and a donor-acceptor distance cut-off of 3.5 Å for hydrogen bonds. The number of hydrogen bonds and vdW energies were normalized by the cross-sectional area. The cross-sectional area was estimated by projecting a fibril layer's vdW surfaces onto the 2D plane perpendicular to the fibril axis. The surfaces corresponding to disordered segments were removed from the analysis. The structural evolution of the models was monitored using root mean-square deviations. The insulin model underwent considerable deformation when the restraints were released and thus did not lead to a stable structure during the production run. For this reason, the SMD simulation described below was carried out on the insulin fibril immediately after a 30,000 step minimization.
Computational determination of the nanomechanical properties
Protein structures were extracted from at least three time points at 5, 10, and 20 ns for the SMD simulations. The proteins were recentered and resolvated in a bigger box to allow for the pulling experiments and the new water molecules were relaxed via a minimization and a 100 ps NPT equilibration step. Pulling experiments were conducted by fixing the bottom layer of each fibril and pulling on the center of mass of the top three layers upward along the fibril axis with a spring constant of 5000 kJ mol À1 nm À2 and a constant velocity of 0.05 Å ps À1 . The force from the SMD run was divided by the cross-sectional area of each fibril and plotted against the engineering strain, s ¼ (l À l 0 )/l 0 where l is the instantaneous fibril length and l 0 is the original length. The peak of the stress-strain curves and the slope in the elastic regime provided estimates of the strength and Young's (elastic) modulus, respectively. The modulus of resilience of the fibrils was calculated from the area under the elastic regime of the stress-strain curves using MATLAB's trapezoidal integration.
Model fibril systems NNQQNX, with X ¼ Y, A, or G TYR residues in the microcrystal structure of the amyloid-like NNQQNY system (35) were mutated to ALA and GLY to serve as potential models for assessing the effects of weakened interlayer interactions on mechanical properties. The simulation procedures described above were applied, except that only 10 ns simulations were carried out because of the similarity of the systems. Structures for the SMD were taken from each run at 5, 7.5, and 10 ns.
RESULTS

PrP fibrils are weaker than insulin fibrils
To map the nanomechanical landscape covered by different amyloids, we measured their (tensile) strength and Young's (elastic) modulus. The mechanical strength corresponds to the amount of stress that can be applied to the fibril before it breaks and, hence, measures the resistance to breaking of the fibril, whereas the Young's modulus provides a measure of fibril's resistance to bending. We derived the fibril's Young's modulus from images taken by AFM ( Fig. S1 ) and TEM ( Fig. S2 ) as described previously (23, 24) (fibril morphological characteristics are analyzed in Figs. S3, S4, and S5). To determine fibril strength, we used a sonication-induced fragmentation technique (25, 31) and a formalism that relates the limiting length, L lim , and the cross-sectional area, h Â w, to the tensile strength, s*: L lim z 7 Â 10 À4 (h Â w) 1/2 (s*) 1/2 , where L lim is the shortest fragment length that can still break (see also Supporting Materials and Methods for details). We determined fragment sizes of sonicated fibrils by both AFM and TEM. First, we analyzed fibrils formed by human insulin, the recombinant wild-type mouse PrP, and the PrP mutant L108F-T189V (FV), whose disease incubation time differs from that of wild-type (36) (see Note S1 in the Supporting Material). The amyloid character of the insulin and several of the PrP fibrils was confirmed by FTIR (24) and x-ray diffraction ( Fig. S6 ).
During sonication, PrP fibrils broke not only longitudinally but also laterally; both TEM images (Figs. 1 A and S7 B) and regularly spaced peaks in the histograms of the width distribution ( Fig. 1 B) suggest that the widths are distributed according to the number of protofilaments. The width (w) and height (h) profiles for each sample were split into individual peaks. Fragment lengths associated with each individual height and width peak were reduced to narrower ranges corresponding to (L lim /2, L lim ). Each individual width peak was combined with its height counterpart to calculate cross-sectional ranges of fibril fragments whose lengths fall in specific terminal ranges (Figs. 1, B and C, right columns). Graphs in Fig. 1 E illustrate the boundaries of the terminal ranges, i.e., how the limiting length varies as a function of the cross-sectional parameter (h Â w) 1/2 . The strength was directly derived from the minimal and maximal aspect ratios, L/(h Â w) 1/2 , describing the extremities of the terminal distribution (black lines). Since only two unique aspect ratios are needed to describe the variation of the terminal distribution across at least four distinct crosssectional ranges, the strength of PrP fibrils does not depend on the number of protofilaments that they contain. Fibril strength was calculated by using (31) L lim /(h Â w) 1/2 z (2s þ S)/2 5 (2sÀS)/2, where s and S are the minimal and maximal aspect ratios (see Materials and Methods for details). This yielded s* ¼ 71 5 36 MPa for the PrP sample in Fig. 1 (FV2b) . Similar low tensile strengths were derived for other fibrils formed by PrP (s* ¼ 18-228 MPa; Fig. S8 ). In contrast, insulin fibrils have significantly higher tensile strength of 496 5 84 MPa ( Fig. 1 ; see also Figs. S9 and S10), which is in agreement with the direct measure of 0.5 5 0.4 GPa obtained previously by using AFM force spectroscopy (2) . PrP fibrils also have a lower Young's modulus than insulin fibrils (Fig. 2 A) . Hence, amyloid fibrils formed by the mouse PrP have very different nanomechanical properties compared to fibrils from insulin: they are softer and weaker.
Next, we sought to confirm that mouse prion fibrils have distinct nanomechanical properties by comparing them to amyloid formed by other proteins that have been shown to be able or not able to confer bona fide prion behavior. Therefore, we determined Young's moduli and tensile strengths for fibrils formed by the NM region of sup35, which contains the minimal region for prion propagation of this protein, the N region of sup35 alone, the fragment 218-289 of HET-s, which is sufficient for induction and propagation of the functional prion state [Het-s], and the nonprion lysozyme. These measurements (see Figs. S4, S5, and S9) reveal that only fibrils formed by the NM region of the yeast prion sup35 are mechanically similar to those of mouse PrP (Fig. 2 B, green) . Fibrils formed by insulin, lysozyme, the HET-s peptide, and sup35N ( Fig. 2 B , orange/red) are much stiffer and stronger.
Correlation between nanomechanics and H-bond densities
To elucidate the molecular features of fibrils that underlie the observed difference in nanomechanics, we analyzed fibril models with the help of SMD simulations. One fibril model of the HET-s peptide (37) and insulin (32) and two models of PrP fibrils (38, 39) were stretched along the fibril axis, which allows determination of the modulus and strength from stress-strain curves ( Figs. 3 A and S11 A) . The models of HET-s and insulin contain the same sequence stretches that were used for the generation of amyloid fibrils analyzed here, whereas the two PrP models used do not include residues 23-88. However, we confirmed experimentally that fibrils formed by PrP(89-231) have a low modulus and low strength, similar to full-length PrP (Fig. 2) . Consistent with experiments, we found that the HET-s fibril model has the highest modulus and highest strength followed by the models of insulin and then PrP (Fig. 3 B) . Although the two PrP fibril models are very different, they have similar nanomechanical properties that are distinct from those of the other fibril models analyzed computationally ( Fig. 3 B) . Compared to all other fibril models tested, they have a much lower modulus of resilience, which quantifies the amount of energy the fibril can absorb before it begins to break (Fig. 3 C) . Both PrP fibril models also have cross sections that are much larger than those of the fibril models of HET-s and insulin (Fig. S11 E) . Therefore, we tested the correlation between hydrogen bond density (HBD) in the fibril models (see Materials and Methods), and the computationally as well as experimentally determined Young's modulus and tensile strength. A statistically significant correlation was found between interlayer HBD and the mechanical properties calculated both computationally (Fig. S11 B) and experimentally ( Fig. 3 D) . Consistent with this correlation are also SMD-based nanomechanics measurements and structural features of an additional available amyloid model, that of Ab42 (Figs. 3, A and B, and  S11 B ). The level of HBD is likely to affect the overall (1, 16, 24) . Fibrillar materials distribute into two distinct elasticity ranges, those held mainly by either strong backbone-backbone interactions (blue band) or those held by weaker interactions characterized by low HBD (green band (1)). For each sample, N ¼ 60-120 fibrils. PrP sample names (green) describe a specific set of experimental conditions used to make fibrils of wild-type (W) and mutant (FV) murine PrP(23-231) (see Materials and Methods for details). Open symbols indicate materials whose elastic Young's moduli have also been measured previously (1,24) using the same approach, which combines flexural rigidity and moment of inertia. (B) Ashby plot of the Young's modulus against tensile strength (mean 5 SD of N ¼ 150-300 fibril fragments). Reference materials are displayed in gray (68, 69) . Stiff and strong amyloid (red and orange) compares well to silk, whereas similarly stiff but weaker amyloid (blue) shares the properties of collagen or tendon. Soft and weak prion fibrils (green) appear to have unique material properties, showing little overlap with other biological materials such as ligament, leather, or cartilage. packing in the fibril core and, hence, the vdW energy across fibril layers (Fig. S11 C) . Indeed, there is a correlation between interlayer vdW energy and mechanical properties (Fig. S11, B and D) . Overall, these results confirm a strong correlation between mechanical properties and packing density of fibril models (27) .
Functional human amyloid fibrils
Although amyloid is mainly studied in the context of human disease, the functional use of amyloid in human cells has come to light (10, 11) . We hence sought to determine the nanomechanical properties of amyloids formed by the RIP1/RIP3 complex, an amyloid signaling complex required for programmed necrosis (29) , and fibrils made of a 54-residue fragment of Toll/interleukin-1 receptor (TIR)-domain-containing adaptor-inducing interferon-b (TRIF), a Toll-like receptor adaptor protein that plays essential roles in the Toll-like receptor pathway (29) . We have recently demonstrated the amyloid nature of the functional fibrils formed by RIP1/RIP3 complex (29) , and new fibril diffraction data also provide evidence for amyloid formation by TRIF (Fig. S6 ). Our measurements reveal that fibrils formed by both the RIP1/RIP3 complex and TRIF have Young's moduli comparable to those of fibrils formed by in-sulin or lysozyme, but tensile strengths that are more similar to those of PrP fibrils (Fig. 2) . Given the similarity between the cross-b x-ray diffraction pattern of RIP1/RIP3 complex and insulin (29) (see also Fig. S6 ), which suggests a typical stacked-sheet structure, Young's moduli on the order of a few gigapascals are not surprising. However, the relatively low strength of these functional human amyloids is intriguing and would contradict a strong correlation between HBD, Young's modulus, and tensile strength (see above).
We hypothesized that the fibril tensile strength may also be sensitive to the packing density of the side chains of neighboring b-strands and that weak or lacking side-chain interactions for a given HBD may give rise to the nanomechanical traits measured for the functional human amyloids. As no models are yet available for fibrils of either RIP1/RIP3 complex or TRIF, we tested our hypothesis with the stacked-sheet fibril model of the NNQQNY peptide (40) . We mutated the tyrosine (TYR) residue to alanine (ALA) and glycine (GLY) and then analyzed water-equilibrated fibril structures ( Fig. 4 A; see Materials and Methods) with the help of SMD. Consistent with our hypothesis, we found that when starting from fibril models with the same HBD, side-chain truncations had no effect on the stiffness (statistically indifferent Young's moduli), but lowered the tensile strength significantly by~200 MPa (Fig. 4 B) . The mutations of TYR to ALA and GLY removed interactions between side chains (Fig. 4 E) and reduced the interlayer vdW energy significantly (Fig. 4 C) . This in turn increased interlayer distances ( Fig. 4 D) , which influenced HBD (Fig. 4 C) by reducing the number of backbone-backbone hydrogen bonds (Fig. 4 E) . However, the decrease in HBD is too low to change Young's moduli significantly (Fig. 4  B) . Overall, these analyses suggest that the amyloid fibrils formed by the RIP1/RIP3 complex and TRIF may have a stacked-sheet structure, but that the side-chain packing may not be as dense as in the fibrils formed by insulin, for instance ( Fig. 3 B) .
DISCUSSION
AFM has provided valuable insights into the structural and mechanical properties of amyloids and the different species that are formed during the protein aggregation process. AFM imaging with statistical analysis of the data (4, 16, 24) as well as direct force measurements (2) have revealed that amyloid fibrils exhibit remarkable mechanical properties. Here, we combine AFM imaging, sonicationinduced scission, and full-atom molecular dynamics simulations to map the mechanical properties of various amyloids. The use of these combined methodologies enables us to determine, for the first time, to our knowledge, the Young's moduli and tensile strengths of a diverse set of amyloids, thereby defining their location on the Ashby plot ( Fig. 2  B) , and to link the derived properties to intermolecular interactions found in model structures of these amyloids.
We find that amyloids cover a broad spectrum of nanomechanical properties in terms of both Young's modulus and tensile strength. At one extreme of this spectrum is amyloid formed by HET-s that has very high stiffness and strength, whereas at the other end are the amyloids formed by PrP and the NM region of sup35 that are soft and weak. Consistent with these experimental findings, SMD models of the HET-s and PrP amyloids provided the highest and lowest Young's modulus and tensile strength, respectively, of all amyloid models analyzed. Amyloid fibrils of insulin have experimentally measured and computationally derived mechanical properties that locate them between these two extremes in the Ashby plot. Importantly, we demonstrate that experimental Young's modulus and tensile strength correlate with the HBD found in the amyloid structure models, at least for the systems for which models are available. HET-s that forms a tightly packed and regular b-helix has the highest HBD, consistent with the high stiffness and strength of the amyloid fibril. In contrast, the PrP fibril models have a much lower number of residues per unit surface that are involved in hydrogen bonds across the interface between two adjacent monomers. This is particularly intriguing for the stacked b-sheet model IS2, which contains multiple b-strands ( Fig. 3 A) . However, the length and location of interacting b-strands in the core of this model are not as regular as in the core of the HET-s fibril structure, and multiple dynamic regions are found between the b-strands, which results in an overall very low HBD. The alternation between structurally ordered and disordered (dynamic) segments in the IS2 model is consistent with solid-state NMR data on PrP fibrils (41) . Hence, our results suggest that fibrils have higher Young's modulus and tensile strength if they accommodate a larger number of residues that form stable hydrogen bonds between b-strands in the fibril core. This conclusion is consistent with recent AFM data suggesting that b-sheet content in protein aggregates correlates with Young's modulus (5) . The mechanical properties of the fibrils formed by the RIP1/RIP3 complex and a 54-residue fragment of TRIF are not fully consistent with this view though. The Young's modulus of amyloid fibrils of the RIP1/RIP3 complex matches the one of insulin fibrils, but their tensile strength is more similar to the one measured for PrP fibrils. This finding suggests that other structural features besides HBD contribute to the fine tuning of the mechanical properties of amyloid fibrils. Consistent with the hypothesis that differences in the packing of the side chains of neighboring b-strands modulate tensile strength, we find that mutations in an amyloid ''toy'' model can change tensile strength without affecting Young's modulus at a significant level. Overall, our combined experimental and computational studies suggest that the ability of sequences to tightly pack into a b-sheet-rich amyloid core is a key determinant of their fibril nanomechanical properties ( Fig. 5 ).
Amyloid fibrils are often very polymorphic, which leads to the question of how robust our experimental findings and the drawn conclusions can be. Indeed, we do see significant variability in terms of width and height within and between samples of the PrP fibrils, for instance ( Fig. S2 ). However, within the approximation that we make in our formalisms to determine the mechanical properties, averages and standard deviations of the Young's moduli and tensile strengths of the different PrP fibril samples are clearly distinct and are lower than those measured for the fibrils of insulin, lysozyme, and HET-s. Importantly, potential systematic errors on AFM heights and TEM widths were taken into account by calculating standard deviations of a large number of experimental measurements (see Materials and Methods). A key approximation in the formalisms that were used to determine Young's modulus and tensile strength is the model for the fibril cross section. A rectangular cross-section model was chosen because the morphology of most fibrils resembles that of flat ribbons. Given that width and height differ significantly in most samples, a circular model would overestimate the Young's modulus (42) , whereas a rectangular cross section provides the most consistent way to calculate the Young's modulus across different samples (see Materials and Methods). Furthermore, the Young's moduli of insulin, lysozyme, and sup35NM amyloids that we determined with this approximation are in good agreement with those measured previously by other groups (1, 2, 43, 44) . Regarding the tensile strength, the deconvolution of the width and height measurements in our approach takes fibril heterogeneity into account. More importantly, the tensile strength that we determined for insulin fibrils is identical to the one directly measured by AFM force spectroscopy (2) . Overall, we are confident that our experimental approach provides robust results for the nanomechanical properties of all systems analyzed here. Regarding the robustness of the SMD results, it may be argued that the amyloid models used in the SMDs may not be accurate representations of the structures present in the fibrils. Focusing on the two systems with the most extreme mechanical properties, the following can be said. The fragment 218-289 of HET-s, which is sufficient for induction and propagation of the functional prion state [Het-s], has been studied extensively by various groups (37, 45) , and all data consistently indicate that it forms a densely packed b-helical structure in the amyloid form like the one present in the solid-state NMR-based model used here. The amyloid model of HET-s has even been used to successfully design mutants and test their prion behavior (46) . Regarding PrP amyloid, these models are certainly of ''lower resolution'' than the HET-s model in the sense that only sparse experimental data were used to generate them. However, the two models that were selected represent two major PrP fibril model categories (see the Supporting Material), and both have low HBDs. The low HBD in the IS2 model is due to the alternation of structurally ordered and disordered segments, which is consistent with solid-state NMR data (41) . Finally, it has to be stressed that the mechanical properties derived from SMDs do not exactly match the experimental values. In particular, Young's moduli are generally overestimated in the theoretical calculations, especially for the PrP models. Besides inaccuracies in the model structure, limit-size effects most likely contribute to the discrepancies between experimentally measured and in silico calculated Young's moduli (see Fig. S11 , E and F, for a comparison of the model and experimentally measured fibril dimensions). Such effects have been described previously (26, 47) . It has been shown that a gradual increase in the number of monomers in a fibril FIGURE 5 Ashby plot summarizing this study. Higher HBD leads to increased Young's modulus and tensile strength. Note that functional nonprions (light blue) have, at the same time, relatively high modulus and low strength (see Figs. 2 and 4 ). model of Ab results in an exponential decay of the calculated Young's modulus, with the converged value matching the experimental one quite closely (48) .
Our findings may have interesting biological implications. We find that amyloid fibrils of PrP and sup35NM, which have been associated with bona fide prion behavior, are soft and weak, which is likely due to rather low packing density and HBD in the fibril core. This would explain why scission-rate constants are high for their amyloids, as previously observed (13, 14) . Given a similar amount of stress, which could be thermal noise or physical interaction with other cell components, weak fibrils like those of PrP and sup35NM will break more easily than the stronger fibrils of insulin and lysozyme. This finding is consistent with the idea that fragmentation efficiency is one of the key features that distinguishes prion from nonprion amyloid (43) . However, amyloid of HET-s(218-289), which can induce a functional prion state (49) , is stiff and strong. This result suggests that high fragmentation rates of amyloid may not be an absolute necessity for prion behavior and that other ''seeding'' mechanisms, such as secondary nucleation, may be equally important for certain prion amyloids. Indeed, it has been shown that the prion state [Het-s] can propagate efficiently by using the lateral surface of fibrils to catalyze the nucleation and subsequent elongation of daughter fibrils (45) (see also Fig. S12 ). It is also interesting to note that multiple strains/variants of sup35 and PrP prions have been identified, and the amyloids they form in vitro showed significant heterogeneity, which is in contrast to the lack of strains and unique amyloid structure found for HET-s (49) . sup35 can form strains that propagate strong and weak phenotypes (50) . Differences in mechanical fragmentation of fibrils formed by sup35NM have been shown to be a key distinguishing factor for weak and strong strains (14) . Consistent with this finding, Castro et al. demonstrated that sup35NM fibrils from strong and weak strains are both soft, but not to the same extent (43) . Importantly, only sup35NM reliably propagates weak and strong strain phenotypes, whereas sup35N, whose stiffness and strength we found to be similar to those of HET-s, can't faithfully maintain weak and strong strains (51) . Based on our finding that fibrils formed by HET-s and sup35N are likely to have a much higher HBD than those formed by PrP and sup35NM, one may speculate that the magnitude of heterogeneity in fibril formation and, thus, the breadth of strain diversity, is inversely related to the existence of a b-sheetrich topology that enables a dense packing of the amyloidcore residues of a given protein, i.e., the existence of an energetically ''dominant'' amyloid state (analogous to the native state of folded proteins). It has to be stressed, though, that our statements on the potential influence of low and high packing density in fibrils on their biological effects are speculative, because we did not test prion behavior or strain association of the fibrils that we grew. Hence, more studies are required to determine whether low HBD of fibrils has biological significance, either by itself or in connection to some other parameters. Of particular interest in this context are amyloids that exist in the form of curvilinear or ''worm-like'' fibrils (e.g., a-lactalbumin and aB-crystallin), which have relatively low persistence length and low modulus (see (1) ) and, therefore, most likely a low HBD. PrP and sup35NM fibrils can also be curvilinear (24, 52) , but they retain low modulus in their mature form, in contrast to other amyloids in which the association of worm-like intermediates gives rise to mature fibrillar forms that have higher moduli (1, 44) .
CONCLUSIONS
Our study demonstrates that amyloid fibrils of different proteins associated with functional and disease-causing behaviors, and with prion and nonprion behaviors, cover a broad spectrum of nanomechanical properties in terms of both Young's modulus and tensile strength. Furthermore, these mechanical properties correlate well with molecular features found in models of such fibrils. These findings suggest that differences in mechanical properties of amyloids are caused by variations in content and packing of b-sheet structure within the fibril core. 
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